Ghent University Academic Bibliography

Advanced

FDG-PET is a predictor of metabolic response to chemotherapy in metastatic colorectal cancer (mCRC)

Nancy Van Damme UGent, SYLVIE DE BRUYNE UGent, Jeroen Mertens UGent, Christophe Van De Wiele UGent, Wim Ceelen UGent, PETER SMEETS UGent, Liesbeth Ferdinande UGent, Stéphanie Laurent UGent, Karen Geboes UGent and Marc Peeters UGent (2011) JOURNAL OF CLINICAL ONCOLOGY. 29(15, suppl.).
Please use this url to cite or link to this publication:
author
organization
year
type
conference
publication status
published
subject
in
JOURNAL OF CLINICAL ONCOLOGY
J. Clin. Oncol.
volume
29
issue
15, suppl.
article_number
abstract e14057
conference name
2011 ASCO annual meeting
conference location
Chicago, IL, USA
conference start
2011-06-03
conference end
2011-06-07
JCR category
ONCOLOGY
JCR impact factor
18.372 (2011)
JCR rank
5/190 (2011)
JCR quartile
1 (2011)
ISSN
0732-183X
language
English
UGent publication?
yes
classification
C3
copyright statement
I have transferred the copyright for this publication to the publisher
id
2047684
handle
http://hdl.handle.net/1854/LU-2047684
date created
2012-02-27 16:19:58
date last changed
2012-03-14 14:09:49
@inproceedings{2047684,
  articleno    = {abstract e14057},
  author       = {Van Damme, Nancy and DE BRUYNE, SYLVIE and Mertens, Jeroen and Van De Wiele, Christophe and Ceelen, Wim and SMEETS, PETER and Ferdinande, Liesbeth and Laurent, St{\'e}phanie and Geboes, Karen and Peeters, Marc},
  booktitle    = {JOURNAL OF CLINICAL ONCOLOGY},
  issn         = {0732-183X},
  language     = {eng},
  location     = {Chicago, IL, USA},
  number       = {15, suppl.},
  title        = {FDG-PET is a predictor of metabolic response to chemotherapy in metastatic colorectal cancer (mCRC)},
  volume       = {29},
  year         = {2011},
}

Chicago
Van Damme, Nancy, SYLVIE DE BRUYNE, Jeroen Mertens, Christophe Van De Wiele, Wim Ceelen, Peter Smeets, Liesbeth Ferdinande, Stéphanie Laurent, Karen Geboes, and Marc Peeters. 2011. “FDG-PET Is a Predictor of Metabolic Response to Chemotherapy in Metastatic Colorectal Cancer (mCRC).” In Journal of Clinical Oncology. Vol. 29.
APA
Van Damme, N., DE BRUYNE, S., Mertens, J., Van De Wiele, C., Ceelen, W., Smeets, P., Ferdinande, L., et al. (2011). FDG-PET is a predictor of metabolic response to chemotherapy in metastatic colorectal cancer (mCRC). JOURNAL OF CLINICAL ONCOLOGY (Vol. 29). Presented at the 2011 ASCO annual meeting.
Vancouver
1.
Van Damme N, DE BRUYNE S, Mertens J, Van De Wiele C, Ceelen W, Smeets P, et al. FDG-PET is a predictor of metabolic response to chemotherapy in metastatic colorectal cancer (mCRC). JOURNAL OF CLINICAL ONCOLOGY. 2011.
MLA
Van Damme, Nancy, SYLVIE DE BRUYNE, Jeroen Mertens, et al. “FDG-PET Is a Predictor of Metabolic Response to Chemotherapy in Metastatic Colorectal Cancer (mCRC).” Journal of Clinical Oncology. Vol. 29. 2011. Print.